Cargando…
Inhibition of Th17 Cells Regulates Autoimmune Diabetes in NOD Mice
OBJECTIVE: The T helper 17 (Th17) population, a subset of CD4-positive T-cells that secrete interleukin (IL)-17, has been implicated in autoimmune diseases, including multiple sclerosis and lupus. Therapeutic agents that target the Th17 effector molecule IL-17 or directly inhibit the Th17 population...
Autores principales: | Emamaullee, Juliet A., Davis, Joy, Merani, Shaheed, Toso, Christian, Elliott, John F., Thiesen, Aducio, Shapiro, A.M. James |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682686/ https://www.ncbi.nlm.nih.gov/pubmed/19289457 http://dx.doi.org/10.2337/db08-1113 |
Ejemplares similares
-
Caspase Inhibitor Therapy Synergizes With Costimulation Blockade to Promote Indefinite Islet Allograft Survival
por: Emamaullee, Juliet A., et al.
Publicado: (2010) -
T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice
Publicado: (1989) -
Inhibition of Autoimmune Diabetes in NOD Mice by miRNA Therapy
por: Wang, Duncheng, et al.
Publicado: (2015) -
TAK1 inhibition prevents the development of autoimmune diabetes in NOD mice
por: Cao, Hui, et al.
Publicado: (2015) -
Effect of Arginase-1 Inhibition on the Incidence of Autoimmune Diabetes in NOD Mice
por: Hernandez, Luis F, et al.
Publicado: (2018)